SanctionsLookup

Data last synced:

Bristol-Myers Squibb OFAC Settlement: $6.6K (2004)

Last updated:

Bristol-Myers Squibb Company on behalf of DuPont Pharmaceuticals Company settled a civil penalty of $6,600.00 for a violation of the Libyan Sanctions Regulations involving a funds transfer and direct export collection with a Libyan SDN in 1999.

Penalty Amount

$6,600.00

Enforcement Date

August 6, 2004

Rank in Top Penalties

#609

Case Details

Type:
Entity
Name:
Bristol-Myers Squibb Company on behalf of DuPont Pharmaceuticals Company
Country:
🇺🇸 United States
Industry:
Healthcare
Address:
New York, NY 10054
Penalty amount:
$6,600.00
Egregious case:
Unknown
Voluntary self disclosure:
Unknown
Case:
Settled
Violation period:
From 1999
Program:
Libya
Enforcement date:
August 6, 2004

Official Source Documents

This page summarizes an OFAC enforcement case based on the document archived below. SanctionsLookup assumes no liability for errors, omissions, or inaccuracies in the original documents, this summary, or any changes made to the source documents at any time.

Provided for informational purposes only and does not constitute legal or compliance advice. Always consult the source document directly rather than relying on this summary.

Archived on June 13, 2026

SHA-256: 5bd1ff59b2f6096a8a152299a47fb44b99cd9e7bee093827dacfbc6c4eaf73d4

More OFAC Cases